AI, Ethics, Leadership and the Future of Pharma: Dr. Laurie Myers, CEO of Hallett Davis Strategic Group | Ep. 44

In this episode of Industry Ignited, Dr. Leeanne Aguilar interviews Dr. Laurie Myers, CEO of Hallett Davis Strategic Group, to unpack how science, ethics, and commercialization must intersect to deliver life-changing medicines. Dr. Myers shares her remarkable transition from toxicology research to senior marketing leadership at global pharma giants, revealing how listening, data translation, and ethical judgment drive successful product launches. She also discusses the future of AI in pharma, the growing importance of truth-verified data sources, lessons from mergers and acquisitions, and why resilience and flexibility remain essential for leaders navigating constant industry change. This conversation highlights the power of cross-functional expertise and why today’s pharmaceutical leaders must balance innovation with responsibility.